These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24505278)

  • 21. Probiotic
    Chiang CJ; Chao YP; Ali A; Day CH; Ho TJ; Wang PN; Lin SC; Padma VV; Kuo WW; Huang CY
    Benef Microbes; 2021 Jun; 12(3):283-293. PubMed ID: 34030609
    [No Abstract]   [Full Text] [Related]  

  • 22. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
    Ukena SN; Singh A; Dringenberg U; Engelhardt R; Seidler U; Hansen W; Bleich A; Bruder D; Franzke A; Rogler G; Suerbaum S; Buer J; Gunzer F; Westendorf AM
    PLoS One; 2007 Dec; 2(12):e1308. PubMed ID: 18074031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers.
    Henker J; Laass M; Blokhin BM; Bolbot YK; Maydannik VG; Elze M; Wolff C; Schulze J
    Eur J Pediatr; 2007 Apr; 166(4):311-8. PubMed ID: 17287932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptive Strategies of the Candidate Probiotic E. coli Nissle in the Mammalian Gut.
    Crook N; Ferreiro A; Gasparrini AJ; Pesesky MW; Gibson MK; Wang B; Sun X; Condiotte Z; Dobrowolski S; Peterson D; Dantas G
    Cell Host Microbe; 2019 Apr; 25(4):499-512.e8. PubMed ID: 30926240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of orally administered probiotic E. coli strain Nissle 1917 on intestinal mucosal immune cells of healthy young pigs.
    Duncker SC; Lorentz A; Schroeder B; Breves G; Bischoff SC
    Vet Immunol Immunopathol; 2006 Jun; 111(3-4):239-50. PubMed ID: 16530848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of probiotic Escherichia coli strain Nissle 1917 lipopolysaccharide on the 5-aminosalicylic acid transepithelial transport across Caco-2 cell monolayers.
    Stětinová V; Smetanová L; Kholová D; Květina J; Svoboda Z; Zídek Z; Tlaskalová-Hogenová H
    Gen Physiol Biophys; 2013 Sep; 32(3):371-80. PubMed ID: 23846256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
    Petersen AM; Mirsepasi H; Halkjær SI; Mortensen EM; Nordgaard-Lassen I; Krogfelt KA
    J Crohns Colitis; 2014 Nov; 8(11):1498-505. PubMed ID: 24972748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
    Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages.
    Hu R; Lin H; Li J; Zhao Y; Wang M; Sun X; Min Y; Gao Y; Yang M
    BMC Microbiol; 2020 Aug; 20(1):268. PubMed ID: 32854612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background.
    Bleich A; Sundberg JP; Smoczek A; von Wasielewski R; de Buhr MF; Janus LM; Julga G; Ukena SN; Hedrich HJ; Gunzer F
    Int J Exp Pathol; 2008 Feb; 89(1):45-54. PubMed ID: 18005134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyrroloquinoline quinone-secreting probiotic Escherichia coli Nissle 1917 ameliorates ethanol-induced oxidative damage and hyperlipidemia in rats.
    Singh AK; Pandey SK; Naresh Kumar G
    Alcohol Clin Exp Res; 2014 Jul; 38(7):2127-37. PubMed ID: 24930470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.
    Henker J; Laass MW; Blokhin BM; Maydannik VG; Bolbot YK; Elze M; Wolff C; Schreiner A; Schulze J
    Pediatr Infect Dis J; 2008 Jun; 27(6):494-9. PubMed ID: 18469732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of Escherichia coli strain Nissle 1917 in the gastro-intestinal diseases].
    Różańska D; Regulska-Ilow B; Choroszy-Król I; Ilow R
    Postepy Hig Med Dosw (Online); 2014 Nov; 68():1251-6. PubMed ID: 25380207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection.
    Schroeder B; Duncker S; Barth S; Bauerfeind R; Gruber AD; Deppenmeier S; Breves G
    Dig Dis Sci; 2006 Apr; 51(4):724-31. PubMed ID: 16614995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probiotic bacteria Escherichia coli strain Nissle 1917 attenuates acute gastric lesions induced by stress.
    Konturek PC; Sliwowski Z; Koziel J; Ptak-Belowska A; Burnat G; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 6():41-8. PubMed ID: 20224150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-inflammatory modulation of immune response by probiotic Escherichia coli Nissle 1917 in human blood mononuclear cells.
    Güttsches AK; Löseke S; Zähringer U; Sonnenborn U; Enders C; Gatermann S; Bufe A
    Innate Immun; 2012 Apr; 18(2):204-16. PubMed ID: 21382908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of E. coli strain Nissle 1917 (EcN) on intestinal gas dynamics and abdominal sensation.
    Hernando-Harder AC; von Bünau R; Nadarajah M; Singer MV; Harder H
    Dig Dis Sci; 2008 Feb; 53(2):443-50. PubMed ID: 17712634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a specific
    Manzhalii E; Moyseyenko V; Kondratiuk V; Molochek N; Falalyeyeva T; Kobyliak N
    World J Hepatol; 2022 Mar; 14(3):634-646. PubMed ID: 35582294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of E. coli Nissle 1917 on post-inflammatory visceral sensory function in a rat model.
    Liebregts T; Adam B; Bertel A; Jones S; Schulze J; Enders C; Sonnenborn U; Lackner K; Holtmann G
    Neurogastroenterol Motil; 2005 Jun; 17(3):410-4. PubMed ID: 15916628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application.
    Ou B; Yang Y; Tham WL; Chen L; Guo J; Zhu G
    Appl Microbiol Biotechnol; 2016 Oct; 100(20):8693-9. PubMed ID: 27640192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.